1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Summary of survey resultsa
Type of PracticeDiscontinue STLMsObserved Postmyelographic Seizure30-Min to 2-Hr Postmyelographic MonitoringNonionic Hypo-Osmolar Contrast>15 Yr in Practice
Academic (n = 281)59% (167)4% (12)69% (193)93% (260)46% (129)
Private practice (n = 316)52% (163)2.2% (7)55% (175)97% (304)66% (207)
Hybrid (n = 100)67% (67)4% (4)54% (54)92% (92)47% (47)
  • ↵a Percentage (No.) of practitioners in different practice group settings and whether they discontinued STLMs, observed a postmyelographic seizure, performed 30-min to 2-hr postmyelographic monitoring, used nonionic hypo-osmolar contrast, and have been in practice >15 yr.